169 related articles for article (PubMed ID: 14680494)
1. Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study.
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Breast Cancer Res; 2004; 6(1):R1-7. PubMed ID: 14680494
[TBL] [Abstract][Full Text] [Related]
2. IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma.
Garcia-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Histopathology; 2005 Jul; 47(1):82-9. PubMed ID: 15982327
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative).
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Cancer Sci; 2006 Oct; 97(10):1044-9. PubMed ID: 16984377
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179
[TBL] [Abstract][Full Text] [Related]
5. Influence of IFN-gamma and its receptors in human breast cancer.
García-Tuñón I; Ricote M; Ruiz A A; Fraile B; Paniagua R; Royuela M
BMC Cancer; 2007 Aug; 7():158. PubMed ID: 17697357
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-1beta in human breast carcinoma.
Jin L; Yuan RQ; Fuchs A; Yao Y; Joseph A; Schwall R; Schnitt SJ; Guida A; Hastings HM; Andres J; Turkel G; Polverini PJ; Goldberg ID; Rosen EM
Cancer; 1997 Aug; 80(3):421-34. PubMed ID: 9241076
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein.
Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS
Cancer; 1995 Apr; 75(8):2123-31. PubMed ID: 7697603
[TBL] [Abstract][Full Text] [Related]
9. Expression of hyaluronan in benign and malignant breast lesions.
Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist.
Miller LJ; Kurtzman SH; Anderson K; Wang Y; Stankus M; Renna M; Lindquist R; Barrows G; Kreutzer DL
Cancer Invest; 2000; 18(4):293-302. PubMed ID: 10808364
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
Gobbi H; Arteaga CL; Jensen RA; Simpson JF; Dupont WD; Olson SJ; Schuyler PA; Plummer WD; Page DL
Histopathology; 2000 Feb; 36(2):168-77. PubMed ID: 10672063
[TBL] [Abstract][Full Text] [Related]
12. OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Cancer Invest; 2008; 26(3):222-9. PubMed ID: 18317962
[TBL] [Abstract][Full Text] [Related]
13. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
[TBL] [Abstract][Full Text] [Related]
14. Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma.
Fan C; Zhao Y; Mao X; Miao Y; Lin X; Jiang G; Zhang X; Han Q; Luan L; Wang E
Tumour Biol; 2014 Nov; 35(11):11337-43. PubMed ID: 25119601
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.
Burrai GP; Mohammed SI; Miller MA; Marras V; Pirino S; Addis MF; Uzzau S; Antuofermo E
BMC Cancer; 2010 Apr; 10():156. PubMed ID: 20412586
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
[TBL] [Abstract][Full Text] [Related]
17. The estrogen receptors alpha, beta, and beta cx.
Shaaban AM; Speirs V
Clin Cancer Res; 2005 Nov; 11(22):8222; author reply 8222-3. PubMed ID: 16299256
[No Abstract] [Full Text] [Related]
18. Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability.
Kuhn DJ; Smith DM; Pross S; Whiteside TL; Dou QP
J Cell Biochem; 2003 Jul; 89(4):824-36. PubMed ID: 12858347
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
Roger P; Sahla ME; Mäkelä S; Gustafsson JA; Baldet P; Rochefort H
Cancer Res; 2001 Mar; 61(6):2537-41. PubMed ID: 11289127
[TBL] [Abstract][Full Text] [Related]
20. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.
Camp BJ; Dyhrman ST; Memoli VA; Mott LA; Barth RJ
Ann Surg Oncol; 1996 Mar; 3(2):176-84. PubMed ID: 8646519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]